Patents by Inventor Sarah A. Gilmore

Sarah A. Gilmore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Interleukin-2 variant proteins fused to human IgG4 Fc and uses thereof
    Patent number: 11896648
    Abstract: Provided are serum half-life extended-IL-2 variant (IL-2v) heterodimers having reduced binding to the IL2R? (CD25) subunit. In particular, Fc-IL-2v heterodimers are provided and methods for making and using, e.g. for enhancing an immune response, e.g. in the prevention and treatment of viral infections and cancer.
    Type: Grant
    Filed: October 20, 2021
    Date of Patent: February 13, 2024
    Assignee: GILEAD SCIENCES, INC.
    Inventors: Manuel Baca, Sarah A. Gilmore, Hassan Javanbakht, Prasenjit K. Mukherjee
  • INTERLEUKIN-2-Fc FUSION PROTEINS AND METHODS OF USE
    Publication number: 20220125884
    Abstract: Provided are serum half-life extended-IL-2 variant (IL-2v) heterodimers having reduced binding to the IL2R? (CD25) subunit. In particular, Fc-IL-2v heterodimers are provided and methods for making and using, e.g. for enhancing an immune response, e.g. in the prevention and treatment of viral infections and cancer.
    Type: Application
    Filed: October 20, 2021
    Publication date: April 28, 2022
    Inventors: Manuel Baca, Sarah A. Gilmore, Magdeleine S. Hung, Hassan Javanbakht, Manu Kanwar, Shahzada Khan, Prasenjit K. Mukherjee, Mark R. Nagel, Giuseppe Papalia, Danny W. Tam, Majlinda K. Thomas